Frankie Ann Holmes (Frankie A Holmes, Frankie Holmes)

Publication Activity (10 Years)

Years Active: 2018-2020
Publications (10 Years): 4

Top Topics

Positive Breast Cancer

Ejection Fraction

Placebo Controlled

Epidermal Growth Factor Receptor

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

NPJ breast cancer

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Ian Krop, Vandana G Abramson, Marco Colleoni, Tiffany Traina, Frankie Ann Holmes, Laura Garcia-Estevez, Lowell Hart, Ahmad Awada, Claudio Zamagni, Patrick G Morris, Lee Schwartzberg, Stephen Chan, Ayca Gucalp, Laura Biganzoli, Joyce Steinberg, Lorenzo Sica, Maureen Trudeau, Denka Markova, Jamal C Tarazi, Zhou Zhu, Thomas O'Brien, Catherine M Kelly, Eric P Winer, Denise A Yardley
A Randomized Placebo Controlled Phase II Trial Evaluating Exemestane with or without Enzalutamide in Patients with Hormone Receptor-Positive Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (23) (2020)
Denis M Collins, Stephen F Madden, Nicola Gaynor, Dalal AlSultan, Marion Le Gal, Alexander J Eustace, Kathy A Gately, Clare Hughes, Anthony M Davies, Thamir Mahgoub, Jo Ballot, Sinead Toomey, Aisling E O'Connor, William M Gallagher, Frankie Ann Holmes, Virginia Espina, Lance Liotta, Bryan T Hennessy, Kenneth J O'Byrne, Max Hasmann, Birgit Bossenmaier, Norma O'Donovan, John Crown
Effects of HER Family-targeting Tyrosine Kinase Inhibitors on Antibody-dependent Cell-mediated Cytotoxicity in HER2-expressing Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (3) (2020)
Devchand Paul, Svetislava J Vukelja, Frankie Ann Holmes, Joanne L Blum, Kristi J McIntyre, Deborah L Lindquist, Cynthia R Osborne, Ines J Sanchez, Jerome H Goldschmidt, Yunfei Wang, Lina Asmar, Lewis Strauss, Joyce O'Shaughnessy
Randomized phase-II evaluation of letrozole plus dasatinib in hormone receptor positive metastatic breast cancer patients. NPJ breast cancer 5 (2019)
Frankie Ann Holmes, Beth A Hellerstedt, John E Pippen, Svetislava J Vukelja, Rufus P Collea, Darren M Kocs, Joanne L Blum, Kristi J McIntyre, Minal A Barve, Barry D Brooks, Cynthia R Osborne, Yunfei Wang, Lina Asmar, Joyce O'Shaughnessy
Five-year results of a phase II trial of preoperative 5-fluorouracil, epirubicin, cyclophosphamide followed by docetaxel with capecitabine (wTX) (with trastuzumab in HER2-positive patients) for patients with stage II or III breast cancer. Cancer medicine 7 (6) (2018)